Literature DB >> 8827513

Naturally occurring mutations in mice affecting lipid transport and metabolism.

K Reue1, M H Doolittle.   

Abstract

Naturally occurring mutations in the mouse provide a unique resource for identifying genes and characterizing proteins involved in lipid metabolism. Spontaneous mouse mutations have been described that affect various aspects of lipid metabolism, including cellular cholesterol homeostasis, fatty acid metabolism, serum lipoprotein levels, serum and tissue lipase activities, and lipid composition of tissues such as liver, nerve, kidney, and adrenal gland. Here we briefly describe the phenotypes and genetics of several mutants with blood and tissue lipid abnormalities, and then provide a more in-depth discussion of two mutations, fatty liver dystrophy (fld) and combined lipase deficiency (cld). Mice homozygous for the fld mutation exhibit fatty liver and hypertriglyceridemia during neonatal development, and a peripheral neuropathy that progresses throughout the lifetime of the animal. Combined lipase deficiency is characterized by a nearly complete absence of lipoprotein lipase and hepatic lipase activity resulting in neonatal lethality. Although the underlying genes for these two disorders have yet to be identified, candidates that have been implicated through the molecular and biochemical characterization of the mutants are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827513

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  The cld mutation: narrowing the critical chromosomal region and selecting candidate genes.

Authors:  Miklós Péterfy; Hui Z Mao; Mark H Doolittle
Journal:  Mamm Genome       Date:  2006-10-03       Impact factor: 2.957

Review 2.  Plasma lipoproteins: genetic influences and clinical implications.

Authors:  Robert A Hegele
Journal:  Nat Rev Genet       Date:  2009-01-13       Impact factor: 53.242

3.  Epithelial-adipocyte interactions are required for mammary gland development, but not for milk production or fertility.

Authors:  Audrey Brenot; Irina Hutson; Charles Harris
Journal:  Dev Biol       Date:  2019-11-04       Impact factor: 3.582

4.  Mechanisms of lipase maturation.

Authors:  Mark H Doolittle; Miklós Péterfy
Journal:  Clin Lipidol       Date:  2010-02-01

5.  Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin.

Authors:  Todd A Huffman; Isabelle Mothe-Satney; John C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 6.  The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

Authors:  Geesje M Dallinga-Thie; Remco Franssen; Hans L Mooij; Maartje E Visser; H Carlijne Hassing; Frank Peelman; John J P Kastelein; Miklós Péterfy; Max Nieuwdorp
Journal:  Atherosclerosis       Date:  2009-12-29       Impact factor: 5.162

7.  Lipase maturation factor LMF1, membrane topology and interaction with lipase proteins in the endoplasmic reticulum.

Authors:  Mark H Doolittle; Saskia B Neher; Osnat Ben-Zeev; Jo Ling-Liao; Ciara M Gallagher; Maryam Hosseini; Fen Yin; Howard Wong; Peter Walter; Miklós Péterfy
Journal:  J Biol Chem       Date:  2009-09-26       Impact factor: 5.157

Review 8.  Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling.

Authors:  Lauren S Csaki; Jennifer R Dwyer; Loren G Fong; Peter Tontonoz; Stephen G Young; Karen Reue
Journal:  Prog Lipid Res       Date:  2013-04-17       Impact factor: 16.195

9.  Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice.

Authors:  Matthew C Gropler; Thurl E Harris; Angela M Hall; Nathan E Wolins; Richard W Gross; Xianlin Han; Zhouji Chen; Brian N Finck
Journal:  J Biol Chem       Date:  2009-01-10       Impact factor: 5.157

10.  Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.

Authors:  Angelo B Cefalù; Davide Noto; Maria Luisa Arpi; Fen Yin; Rossella Spina; Hannele Hilden; Carlo M Barbagallo; Antonio Carroccio; Patrizia Tarugi; Sebastiano Squatrito; Riccardo Vigneri; Marja-Riitta Taskinen; Miklós Péterfy; Maurizio R Averna
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.